Literature DB >> 1678471

p53 immunostaining as a marker of malignant disease in diagnostic cytopathology.

P A Hall, A Ray, N R Lemoine, C A Midgley, T Krausz, D P Lane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1678471     DOI： 10.1016/0140-6736(91)90586-e

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  22 in total

1.  p53 expression in lymphatic malignancies.

Authors:  Y Soini; P Pääkkö; M Alavaikko; K Vähäkangas
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

Review 2.  The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1998-04

3.  p53 gene mutations are not required for early dissemination of cancer cells.

Authors:  S Offner; W Schmaus; K Witter; G B Baretton; G Schlimok; B Passlick; G Riethmüller; K Pantel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

4.  p53 expression in dyskeratosis congenita: a marker for oral premalignancy?

Authors:  G R Ogden; D P Lane; D M Chisholm
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

5.  p53 protein expression in central nervous system neoplasms.

Authors:  M Barbareschi; P Iuzzolino; A Pennella; A Allegranza; G Arrigoni; P Dalla Palma; C Doglioni
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

6.  Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease.

Authors:  R K Gupta; K Patel; W F Bodmer; J G Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

7.  Immunohistochemical analysis of p53 expression in anal squamous neoplasia.

Authors:  O A Ogunbiyi; J H Scholefield; J H Smith; S V Polacarz; K Rogers; F Sharp
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

8.  Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone.

Authors:  Y Ueda; B Dockhorn-Dworniczak; S Blasius; W Mellin; P Wuisman; W Böcker; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  Clinical significance of Ki-67 and p53 expression in curatively resected non-small cell lung cancer.

Authors:  Hee Kyung Ahn; Minkyu Jung; Seung-Yeon Ha; Jae-Ik Lee; Inkeun Park; Young Saing Kim; Junshik Hong; Sun Jin Sym; Jinny Park; Dong Bok Shin; Jae Hoon Lee; Eun Kyung Cho
Journal:  Tumour Biol       Date:  2014-04-16

10.  Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product.

Authors:  J M van Es; M M Polak; F M van den Berg; T B Ramsoekh; M E Craanen; R H Hruban; G J Offerhaus
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.